Pyratel CD 5 mg/ml , internal antiparasitic for dogs and cats

COMPOSITION
1 ml suspension contains:
Active substance:
Pyrantel base ……………………………………………………………………………5 mg
(equivalent to 14.4 mg/ml pyrantel pamoate)
Excipients:
Methyl parahydroxybenzoate …………………………………………………1.8 mg
Propyl parahydroxybenzoate ………………………………………………….0.2 mg
Homogeneous, yellow colored suspension.
INDICATIONS
The veterinary medicinal product is administered to dogs and cats in
the treatment of parasitosis caused by the following gastrointestinal
nematodes: Toxocara spp. (Toxocara canis, Toxocara cati), Toxascaris
leonina, Ancylostoma canium, Uncinaria stenocephala.
CONTRAINDICATIONS
Do not use in weak animals.
Do not use in cases of hypersensitivity to the active substance or to
any of the excipients.
ADVERSE REACTIONS
Rare (1 to 10 animals/10.000 treated animals): vomiting, diarrhoea.
TARGET SPECIES
Dogs, cats.
ADMINISTRATION
Oral use, using a syringe, directly into the oral cavity or mixed with
food, in the following doses:
• Dogs: 5 mg pyrantel base/kg b.w., equivalent to 1 ml veterinary
medicinal product/kg b.w.
• Cats: 20 mg pyrantel base/kg b.w., equivalent to 4 ml veterinary
medicinal product/kg b.w.
Puppies and kittens up to 12 weeks of age:
The first treatment is given on the 14th day of life, and subsequent
treatments at two-week intervals until the age of 10 weeks. If the
infestation persists, it is recommended to continue the treatment at
two-week intervals until the animal is 12 weeks old.
Dogs and cats over 12 weeks of age:
For animals living in satisfactory hygienic conditions, it is sufficient
to treat them regularly at 3-month intervals. In cases of poor hygiene
and in conditions of excessive heat and humidity, which favor the
development of parasites, the animals should be treated according
to medical advice.
Pregnant and lactating female dogs and cats:
Cats should be treated at 2, 4 and 6 weeks after each heat cycle.
Pregnant females will be treated approximately 10 days before
parturition and at 2, 4, 6, 8 and 10 weeks after each birthing (together
with their puppies/kittens). Outside these periods, the treatment
of animals living in good hygienic conditions will be repeated at
3-month intervals.
If the infestation persists, it is recommended to continue the
treatment at 2-week intervals.
RECOMMENDATIONS FOR PROPER ADMINISTRATION
No dietary measures are necessary before administering the
product. To ensure correct dosing, body weight should be determined
as accurately as possible. Underdosing may lead to ineffective use
and may promote the development of resistance. Shake before use.
USE IN THE CASE OF PREGNANCY, LACTATION
Can be used during pregnancy and lactation.
INTERACTIONS WITH OTHER MEDICINAL PRODUCTS OR OTHER
FORMS OF INTERACTION
Simultaneous treatment with other antiparasitic products is not
recommended. In the absence of compatibility studies, this veterinary
medicinal product should not be administered concomitantly with
other veterinary medicinal products.
OVERDOSE
Administered at a dose 5 times higher than the recommended one
it did not produce adverse effects. Overdosing should be avoided.
MAJOR INCOMPATIBILITIES
It is incompatible with products containing: morantel, levamisole,
piperazine and organophosphorus compounds.
In the absence of compatibility studies, this veterinary medicinal
product must not be mixed with other veterinary medicinal products.
WITHDRAWAL PERIOD
Not applicable.
STORAGE
Store at a temperature below 25°C. Store in the original packaging.
Keep the packaging tightly closed. Protect from direct light. Protect
from frost.

PRESENTATION
Bottle x 100 ml and a dosing device in the form of a syringe.